OLD Category: immuno-oncology
November 17, 2020 / J Immunother Cancer
Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer
November 16, 2020 / Clin Cancer Res
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
November 16, 2020 / Am J Transl Res
The expression, modulation and use of cancer-testis antigens as potential biomarkers for cancer immunotherapy
November 6, 2020 / J Immunother Cancer
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
November 2, 2020 / J Clin Invest
Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance
November 2, 2020 / J Immunother Cancer
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy
October 29, 2020 / Cancer Immunol Immunother
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity
October 29, 2020 / J Immunother Cancer
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses
October 27, 2020 / J Immunother Cancer
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma
October 24, 2020 / Adv Radiat Oncol
3,3′-Diindolylmethane Enhances Tumor Regression After Radiation Through Protecting Normal Cells to Modulate Antitumor Immunity
October 20, 2020 / J Immunother Cancer